日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53.

CC 基序趋化因子受体样 2 促进具有红系分化和 TP53 突变的髓系肿瘤中的干扰素-γ 信号反应。

Naji Nour Sabiha, Pasca Sergiu, Chatzilygeroudi Theodora, Toledano-Sanz Pablo, Rimando Joseph, An Yuju, Hemani Yashvi, Perkins Brandy, Zeng Xinghan, Talbot Conover Jr, Paun Bogdan, Abdulmalik Abdulmuez, Lossos Chen, Boronina Tatianna R, Sinanidis Ilias, Tsakiroglou Panagiotis, Fernandes Priyanka, Esteb Christopher, Ambinder Alexander J, Cole Robert N, Xian Rena, Gojo Ivana, Paul Suman, Levis Mark J, DeZern Amy E, Luznik Leo, Karanika Styliani, Resar Linda S, Jones Richard J, Bunz Frederick, Gondek Lukasz, Arvanitis Marios, Karantanos Theodoros

Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with highdose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy

在移植前治疗效果日益显著的时代,采用高剂量移植后环磷酰胺治疗异基因造血干细胞移植或骨髓移植可改善急性淋巴细胞白血病患者的预后。

Webster, Jonathan A; Reed, Madison; Tsai, Hua-Ling; Imus, Philip H; Smith, Douglas B; Ambinder, Alexander J; Levis, Mark J; DeZern, Amy E; Prince, Gabrielle T; Jain, Tania; Bolaños-Meade, Javier; Gondek, Lukasz P; Ghiaur, Gabriel; Dalton, William Brian; Karantanos, Theodoros; Paul, Suman; Fuchs, Ephraim J; Sterling, Cole; Swinnen, Lode J; Wagner-Johnston, Nina; Ambinder, Richard F; Gocke, Christian B; Ali, Syed Abbas; Huff, Carol Ann; Luznik, Leo; Varadhan, Ravi; Jones, Richard J; Gojo, Ivana

Immune-related encephalitis after immune checkpoint inhibitor therapy

免疫检查点抑制剂治疗后发生的免疫相关性脑炎

Buckley, Monica W; Balaji Warner, Aanika; Brahmer, Julie; Cappelli, Laura C; Sharfman, William H; Fuchs, Ephraim; Kang, Hyunseok; Forde, Patrick M; Gladstone, Douglas E; Ambinder, Richard; Kelly, Ronan J; Lipson, Evan J; Gojo, Ivana; Lee, Edward J; Johnson, Tory P; Saidha, Shiv; Llinas, Rafael; Ostrow, Lyle W; Naidoo, Jarushka; Probasco, John C

Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities

blinatumomab治疗CD19+急性白血病患者的疗效和安全性研究(患者既往因合并症而被排除在临床试验之外)

Claiborne, J Preston; Li, Daniel; Tsai, Hua-Ling; Ghiaur, Gabriel; Smith, B Douglas; Levis, Mark J; DeZern, Amy E; Ambinder, Alex J; Jain, Tania; Prince, Gabrielle T; Gondek, Lukasz P; Karantanos, Theodoros; Dalton, W Brian; Gojo, Ivana; Webster, Jonathan A

CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53

CCRL2促进具有红系分化和TP53突变的髓系肿瘤中的干扰素-γ信号反应

Naji, Nour Sabiha; Pasca, Sergiu; Chatzilygeroudi, Theodora; Toledano-Sanz, Pablo; Rimando, Joseph; Hemani, Yashvi; Perkins, Brandy; Zeng, Xinghan; Talbot, Conover; Paun, Bogdan; Abdulmalik, Abdulmuez; Lossos, Chen; Boronina, Tatianna R; Sinanidis, Ilias; Tsakiroglou, Panagiotis; Fernandes, Priyanka; Esteb, Christopher; Ambinder, Alexander J; Cole, Robert N; Xian, Rena; Gojo, Ivana; Paul, Suman; Levis, Mark J; DeZern, Amy E; Luznik, Leo; Karanika, Styliani; Resar, Linda S; Jones, Richard J; Bunz, Frederick; Gondek, Lukasz; Arvanitis, Marios; Karantanos, Theodoros

Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AML

对于年龄在 60 至 75 岁之间、预后良好且携带 NPM1 突变的急性髓系白血病 (AML) 患者,强化化疗与维奈托克/去甲基化药物的比较

Zale, Andrew D; Sandeep Kaduluri, Venkata Preetam; Webster, Jonathan A; Levis, Mark J; Gojo, Ivana; DeZern, Amy E; Ghiaur, Gabriel; Gondek, Lukasz P; Dalton, William Brian; Karantanos, Theodoros; Jain, Tania; Prince, Gabrielle T; Jones, Richard J; Smith, B Douglas; Ambinder, Alexander J

CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia

CD8+ T细胞分化和功能障碍可提示急性髓系白血病的治疗反应

Mazziotta, Francesco; Biavati, Luca; Rimando, Joseph; Rutella, Sergio; Borcherding, Nicholas; Parbhoo, Sonali; Mukhopadhyay, Rupkatha; Chowdhury, Sayan; Knaus, Hanna A; Valent, Peter; Hackl, Hubert; Borrello, Ivan M; Blazar, Bruce R; Hatzi, Katerina; Gojo, Ivana; Luznik, Leo

Outcome heterogeneity of TP53-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantation

TP53突变型髓系肿瘤预后异质性及异基因造血干细胞移植的作用

Pasca, Sergiu; Haldar, Saurav D; Ambinder, Alexander; Webster, Jonathan A; Jain, Tania; Dalton, W Brian; Prince, Gabrielle T; Ghiaur, Gabriel; DeZern, Amy E; Gojo, Ivana; Smith, B Douglas; Karantanos, Theodoros; Schulz, Cory; Stokvis, Kristin; Levis, Mark J; Jones, Richard J; Gondek, Lukasz P

Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years

异基因造血干细胞移植联合大剂量移植后环磷酰胺治疗年龄≥55岁的急性淋巴细胞白血病

Webster, Jonathan A; Reed, Madison; Tsai, Hua-Ling; Ambinder, Alexander; Jain, Tania; Dezern, Amy E; Levis, Mark J; Showel, Margaret M; Prince, Gabrielle T; Hourigan, Christopher S; Gladstone, Douglas E; Bolanos-Meade, Javier; Gondek, Lukasz P; Ghiaur, Gabriel; Dalton, W Brian; Paul, Suman; Fuchs, Ephraim J; Gocke, Christian B; Ali, Syed Abbas; Huff, Carol Ann; Borrello, Ivan M; Swinnen, Lode; Wagner-Johnston, Nina; Ambinder, Richard F; Luznik, Leo; Gojo, Ivana; Smith, B Douglas; Varadhan, Ravi; Jones, Richard J; Imus, Philip H

Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia

免疫功能障碍特征可预测急性髓系白血病的预后并定义对检查点阻断无反应的微环境。

Rutella, Sergio; Vadakekolathu, Jayakumar; Mazziotta, Francesco; Reeder, Stephen; Yau, Tung-On; Mukhopadhyay, Rupkatha; Dickins, Benjamin; Altmann, Heidi; Kramer, Michael; Knaus, Hanna A; Blazar, Bruce R; Radojcic, Vedran; Zeidner, Joshua F; Arruda, Andrea; Wang, Bofei; Abbas, Hussein A; Minden, Mark D; Tasian, Sarah K; Bornhäuser, Martin; Gojo, Ivana; Luznik, Leo